American Society for Bone and Mineral Research (ASBMR) Educational Resource focus on Osteoporosis

Un curso de diez lecciones con revisiones científicas en formato e-learning. Dispondrás de las últimas novedades en la atención a los pacientes con osteoporosis tanto en el estudio de la enfermedad como en el manejo de los pacientes en su práctica clínica.

Este programa está patrocinado por Stada y cuenta con el aval científico de la SEIOMM (Sociedad Española de Investigación Ósea y Metabolismo Mineral).

Completando el curso, serás capaz de resumir las novedades en la investigación y desarrollo sobre homeostasis mineral, osteoporosis y otras enfermedades metabólicas óseas, como tecnologías de medición esquelética y genética.

Fechas: 27/02/2026 – 26/02/2027
Se han solicitado créditos al Sistema Nacional de Salud (20h lectivas)
No:  09/000000-MD

Lección 1: Body mass index and subsequent fracture risk: a meta-analysis to update FRAX (2h)
27/02/26

Lección 2: Mortality from vertebral fractures in White women aged 65+ with osteoporosis: a CDC data base trend an alysis from 1999 to 2020 (2h) 
27/02/26

Lección 3: Real-world differences in denosumab persistence, reinitiation, and switching among cohorts of older adults in Canada and the United States (2h) 
27/03/26

Lección 4: Associations between body composition and bone loss in early postmenopausal women (2h) 
27/03/26

Lección 5: Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures (2h) 
24/04/26

Lección 6: Frailty and osteoporotic fractures represent mutual risks for each other with common physiological backgrounds (2h) 
24/04/26

Lección 7: 24-hour activity composition is associated with lower fall and fracture risk in older men (2h) 
22/05/26

Lección 8: Bone turnover markers as predictors of hypocalcemia in patients with bone metastases receiving denosumab (2h) 
22/05/26

Lección 9: Prediction of hip fracture by high-resolution peripheral quantitative computed tomography in older Swedish women (2h) 
26/06/26

Lección 10: The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project (2h) 
26/06/26

Fechas: 05/05/2025 – 04/05/2026
3,5 créditos (20h lectivas)
No:  09/039815-MD

Lección 1: Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project (2h)
05/05/25

Lección 2: Simultaneous automated ascertainment of prevalent vertebral fracture and abdominal aortic calcification in clinical practice: role in fracture risk assessment (2h)
05/05/25

Lección 3: Defining the key clinician skills and attributes for competency in managing patients with osteoporosis and fragility fractures (2h) 
09/06/25

Lección 4: Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study (2h)
09/06/25

Lección 5: Complex clinical encounter series: osteoporosis presenting during pregnancy and lactation: wait and reassess (2h)
07/07/25

Lección 6: High physical activity is associated with greater cortical bone size, better physical function, and with lower risk of incident fractures independently of clinical risk factors in older women from the SUPERB study (2h)
07/07/25

Lección 7: Femoral neck width genetic risk score is a novel independent risk factor for hip fractures (2h)
01/09/25

Lección 8: Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study (2h)
06/10/25

Lección 9: Treating osteoporosis in patients with atypical femoral fracture (2h)
03/11/25

Lección 10: Association of vertebral fractures with worsening degenerative changes of the spine: a longitudinal study (2h)
01/12/25